Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation

Cited by (1,000)

Items 801–900 of 1,000

  1. Fármacos con acción GLP-1 en el tratamiento de la obesidad: efectos sobre las variables cardiometabólicas y la enfermedad cardiovascular
    Helena Sardà, Idoia Genua, Inka Miñambres · 2025 · Medicina Clínica
  2. Differential Associations of Cardiac, Pulmonary, Arterial, and Muscle Physiological Parameters and Biomarkers With the Incidence of HFpEF and HFrEF
    Fernando Giugni, Yimin Yang, Brian Lee Claggett, Victoria Lamberson, Scott David Solomon, Pamela L. Lutsey, Dalane W. Kitzman, Chiadi E. Ndumele, Thomas H. Mosley, Patricia P. Chang et al. · 2025 · JACC Heart Failure
  3. Comparative performance of multiple inflammatory indices across different stages of cardiovascular-kidney-metabolism syndrome: A Multi-Cohort Study
    Lingyuan Hu, Zhuotong Wang, Jiaqi Chen, Aomiao Chen, Geningyue Wang, Xinran Xie, Qian He, Yaoming Xue, Zhiyong Wu, Zongji Zheng et al. · 2025 · Endocrine
  4. Coronary Artery Calcium Scoring Improves Allocation of the GLP-1 Receptor Agonist Semaglutide
    Robert A. Kloner, Matthew Jay Budoff · 2025 · JACC. Cardiovascular imaging
  5. Rising Prevalence of Cardiovascular-Kidney-Metabolic (CKM) Syndrome in China, 2010-2019: National Cross-Sectional Surveys
    Daijun He, Xiao Zhang, Chenglong Li, Chao Yang, Mengting Yu, Jinwei Wang, Jiakang Huo, Bixia Gao, Minghui Zhao, Mei Zhang et al. · 2025 · medRxiv
  6. Remnant cholesterol, the cardiovascular-kidney-metabolic syndrome, and cardiovascular disease: lessons from CHARLS
    Marcio Hiroshi Miname, Raul Dias Santos · 2025 · European Journal of Preventive Cardiology
  7. MASLD in the cardiovascular–kidney–metabolic health framework: what does it add to the table?
    Kyoung Hwa Ha, Dae Jung Kim, Hokyou Lee · 2025 · European Journal of Preventive Cardiology
  8. Assessing Medical Therapy Optimization in Cardiovascular-Kidney-Metabolic Clinical Trials
    Ankeet S. Bhatt, Diana De Oliveira-Gomes, Mona Fiuzat, Muthiah Vaduganathan, CARINE E. HAMO, Norman Stockbridge, Javed Butler, Mitchell A. Psotka, William T. Abraham, Darren K. McGuire et al. · 2025 · JACC Heart Failure
  9. Beyond the Beat: A Cardiac Anesthesiologist's Perspective on Cardiovascular-Kidney-Metabolic Health in Perioperative Care
    Brian J. Gebhardt, Ankit Jain · 2024 · Journal of Cardiothoracic and Vascular Anesthesia
  10. Integrated Cardiorespiratory Rehabilitation and Its Impact on Cardio–Renal–Metabolic Profile After Cardiac Surgery
    Stefanie Marek‐Iannucci, Alberto Palazzuoli, Matteo Babarto, Zlatan Lazarevic, Matteo Beltrami, Francesco Fedele · 2024 · Nutrients
  11. Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome
    Kevin Bryan Lo, Karim Iskarous, Rajiv Sankaranarayanan · 2025 · Cardiology Clinics
  12. Have SGLT-2 inhibitors DELIVERed an EMPhatic win in heart failure and chronic kidney disease?
    Awadhesh Kumar Singh, Akriti Singh, Ritu Singh · 2025 · Expert Opinion on Pharmacotherapy
  13. The community health worker model for cardiovascular kidney metabolic syndrome: A new paradigm for high value care
    Sanjay Rajagopalan, Jeshurun Adarquah-Yiadom, Fonda Mcclain, John Pastor Ansah, Heidi Osborne, Kimberly W. Nicholson, Zoe Landskroner, Kyia Mountain, Elke Eaton, Jodie Porges et al. · 2025 · American Journal of Preventive Cardiology
  14. Cardiovascular-Kidney-Metabolic Health
    Melinda Solomon, Sophie E. Claudel, Ashish Verma · 2025 · Cardiology Clinics
  15. Association between serum α-klotho levels and the incidence of diabetic kidney disease and mortality in type 2 diabetes: evidence from a Chinese cohort and the NHANES database
    Yi Kang, Qian Jin, Mengqi Zhou, Huijuan Zheng, D R Li, Jingwei Zhou, Jie Lv, Yaoxian Wang · 2025 · Diabetology & Metabolic Syndrome
  16. Sex differences in the association between albuminuria and vascular health in individuals living with chronic kidney disease
    Badal S B Pattar, Sofia Bano Ahmed, Jessalyn K. Holodinsky, Nicole Larsen, Sakshi Kharbanda, Sarah Rabi, Victoria J. Riehl-Tonn, Darlene Y. Sola, Sarah Blayney, Sandra Marie Dumanski · 2025 · Current Research in Physiology
  17. Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration
    Nick S.R. Lan, Jonathan Hiew, Ivana Ferreira, Jens Carsten Ritter, Laurens A. Manning, P. Gerry Fegan, Girish Dwivedi, Emma Jane Hamilton · 2025 · Journal of Diabetes and its Complications
  18. All-Russian observational non-interventional program on the study of the efficacy of Subetta in real-world clinical practice in patients with prediabetes (SILA)
    Alexey V. Zilov, Л. З. Болиева · 2025 · Meditsinskiy sovet = Medical Council
  19. Dietary Patterns, Habits, and the Rising Burden of Noncommunicable Diseases in India
    Umesh B. Khanna, Hiral Shah · 2025 · Indian Journal of Kidney Diseases
  20. Investigation of early-stage cardiovascular-kidney-metabolic syndrome on retinal structure and function evaluated by optical coherence tomography angiography
    Yunyi Liang, Congbi Liang, Jianping Yang, Wanhua Li, Runyi Liang, Kun Li, Jingfeng Zhang, Peiqiong Lao, Junhua Zhu, Lin An et al. · 2025 · Frontiers in Medicine
  21. Feasibility of the Implementation of Tools for Heart Failure Risk Prediction
    Michael C. Wang, Bridget Dolan, Xiaoning Huang, Priya Mehta Freaney, Benjamin H. Freed, Lourdes Vega, Nikola Markoski, Amy E. Wainright, Bonnie J. Kane, Laura E. Seegmiller et al. · 2025 · JACC Advances
  22. Contemplative Practices as a Form of Stress Management for Patients with Kidney Disease
    Marino A. Bruce, Roland J. Thorpe, Robert H. Schneider, Adam Engel Hercz, Sandra F. Williams, Keith C. Norris · 2025 · Clinical Journal of the American Society of Nephrology
  23. Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011–2023
    Dingyuan Tu, Shuhui Ju, Yu Xue, Weijuan Xie, Cong Wu, Chaoqun Ma, Qiang Xu · 2025 · Respiratory Medicine
  24. Cardiovascular-Kidney-Metabolic Syndrome: A Paradigm for Value-Based Care
    Zachary Hermes, Ankeet S. Bhatt, Muthiah Vaduganathan · 2025 · Journal of Cardiac Failure - Intersections
  25. Novel approaches and applications in identifying DNA methylation markers of cardio-kidney-metabolic disease
    Chang Liu, Alexandra Young, Nanzha Abi, Junyu Chen, Matheus Fernandes Gyorfy, Yanping Li, Sophia Sun, Jin J. Zhou, Yan V. Sun · 2025 · Epigenomics
  26. Association Between Oxidative–Inflammation Biomarkers and Incident Chronic Kidney Disease in People with High Cardiovascular Risk: A Nested Case–Control Study
    Maria Magdalena Quetglas‐Llabrés, Andrés Díaz‐López, Cristina Bouzas, Margalida Monserrat-Mesquida, Jordi Salas‐Salvadó, Miguel Ruiz‐Canela, José Alfredo Martínez, José Manuel Santos‐Lozano, Silvia García, Ramón Estruch et al. · 2025 · Antioxidants
  27. Associations Between Fatigue and Cardiovascular–Kidney–Metabolic Syndrome and the Mediating Role of Inflammation
    Yunxia Xie, Keqing Shen, Jingping Xu, Lusha Li, Liying Chen · 2025 · Diabetes Metabolic Syndrome and Obesity
  28. Identification and management of patients at high-risk for cardiovascular disease in primary prevention
    Michael J. Ahlers, Sonya John, Harpreet Singh Bhatia, Viet T. Le, Pam R. Taub · 2025 · American Journal of Preventive Cardiology
  29. Association of the Dietary Index for Gut Microbiota and Cardiovascular‐Kidney‐Metabolic Syndrome: The Mediation Effect of Phenotypic and Biological Age Acceleration, BMI , and BRI
    Dongdong Yu, Ting Yuan David Cheng, Yuxuan Shi, Xingying Qiu, Li Geng, Yue Yang, Li Zhou, Zehuai Wen · 2025 · Food Science & Nutrition
  30. A 7‐year prospective analysis of sustained benefits of multicomponent risk assessment and data‐driven care in patients with type 2 diabetes: The Malaysian JADE Program
    Jia‐Xin Hoo, Ya‐Feng Yang, Eric S. H. Lau, Luqman Ibrahim, Shireene Ratna Vethakkan, Jeyakantha Ratnasingam, Siew-Pheng Chan, Sharmila Sunita Paramasivam, Yook Chin Chia, Alexander Tong Boon Tan et al. · 2025 · Diabetes Obesity and Metabolism
  31. Development of an optimized risk evaluation system for cardiovascular-kidney-metabolic syndrome-associated coronary heart disease based on tabular prior-data fitted network
    Shidian Zhu, Hui Zhang, Yanlin Liu, Wenyu Bu, Qiang Wu, Jin Wang, Wandi Chen, Qizhe Wu, Zhirong Geng, Fumin Liu · 2025 · Digital Health
  32. The effect of low-dose aspirin on reversing frailty status in older prefrail and frail adults: a secondary analysis of the ASPREE randomised clinical trial
    Ananta P Handono, Joanne L. Ryan, Fajar Setiawan, Sara E Espinoza, Aung Zaw Zaw Phyo, Chao Zhu, Mark Raymond Nelson, Michael E. Ernst, Suzanne Gaye Orchard, Rory S Wolfe et al. · 2025 · Age and Ageing
  33. Role of hypertension in the cardiovascular-kidney-metabolic syndrome among black adults: The Jackson Heart Study
    Lama Ghazi, Medha Dubal, Alain Gerald Bertoni, April P. Carson, Bessie Ann Young, Cora Elizabeth Lewis, Chibuike J Alanaeme, Dayna A. Johnson, Daichi Shimbo, Kathryn E. Foti et al. · 2025 · Journal of Human Hypertension
  34. Sex Differences in Early Stages of Cardiorenometabolic Syndrome in Young Adults
    Альбина Владимировна Синеглазова, Гузель Равильевна Садыкова, SWAPNIL D. PARVE · 2025 · Cureus
  35. Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population‐Based Study (2009–2018)
    Mustafa Hussein Ajlan Al-Jarshawi, Ofer M. Kobo, Dennis T. Ko, Harindra Channa Wijeysundera, M. Golam Azam, Victoria Silverwood, Ram Chandra Bajpai, Rodrigo Bagur, Mamas A. Mamas · 2025 · Journal of the American Heart Association
  36. A Murine Model of Cardiovascular-Kidney-Metabolic Syndrome Demonstrates Compromised Limb Function in the Ischemic Hind Limb
    Saran Lotfollahzadeh, Herreet Paul, Joshua Bonifacio, Ricardo Almiron, Isaac Hoekstra, Kylla A. Przekop, Trent Yamamoto, Maria Del Carmen Piqueras, Wenqing Yin, Kashvi Sethuraman et al. · 2025 · Kidney360
  37. Identification of IL18/IL18R1 signaling as a predictive biomarker of SGLT2 inhibitor efficacy in type 2 diabetes
    I-Jou Teng, Chien-Hsing Lee, Ying-Chen Chen, Sheng‐Chiang Su, Chieh‐Hua Lu, Pengfei Li, Chia‐Luen Huang, Li-Ju Ho, Ming-Hsun Lin, Hsin-Ya Liu et al. · 2025 · iScience
  38. The New Modern Medicine
    Jonathan Fuller · 2025
  39. Association Between Serum Micronutrients and Advanced CKM Syndrome: An Interpretable Machine Learning‐Based Study
    Yi Ou, Xinyi Shao, Yidian Fu, Xiang Qu, Yuan Zhan, Qian Liu, Jin Chen, Aijun Chen, Genlong Bai, Jingbo Zhang · 2025 · Food Science & Nutrition
  40. Cardiovascular implications of glomerular filtration rate alterations beyond conventional chronic kidney disease classification
    Rodolfo Valtuille · 2025 · Postgraduate Medicine
  41. Circulating and Urinary CCL20 in Human Kidney Disease
    Noelia Molina-Cazallas, Diego García-Ayuso, Beatriz Fernández‐Fernández, Laura Rodríguez-Osorio, Jinny E. Sánchez-Rodríguez, María Vanessa Pérez-Gómez, Alberto Ortíz, Adrian Mario Ramos · 2025 · International Journal of Molecular Sciences
  42. Prerenalism—A Gap That Costs Lives, Hearts, and Kidneys
    Janani Rangaswami, Katherine R. Tuttle · 2025 · JAMA Cardiology
  43. Protective association of renin‐angiotensin system inhibitor use with skeletal muscle wasting in diabetic heart failure
    Hidemichi Kouzu, Toshiyuki Yano, Satoshi Katano, Wataru Kawaharata, Ryo Numazawa, Ryohei Nagaoka, Hiroki Aida, Katsuhiko Ohori, Takefumi Fujito, Nobutaka Nagano et al. · 2025 · Journal of Diabetes Investigation
  44. Association Between Inflammatory Dietary Pattern and Cardiovascular-Kidney-Metabolic Syndrome: A Population-Based Study
    Shasha Shang, Zhili Li, Hao-dong Liu, Shanshan Li, Kai Zheng, Lei Ruan · 2025 · Current Medical Science
  45. Beyond the association: towards an integrated hepato–renal approach
    Juanita Pérez-Escobar, Ricardo Iván Velázquez-Silva, Paulina Carpinteyro‐Espín, José Carlos Gasca-Aldama · 2025 · Annals of Hepatology
  46. Integration of BNP and blood glucose for identifying coronary flow reserve impairment: A cardiovascular–kidney–metabolic perspective
    Kotaro Matsumoto, Kenichiro Otsuka, Shunsuke Kagawa, Hiroki Yamaura, Tsubasa Miura, Kazuya Sugioka, Wataru Saitoh, Akihiro Okamoto, Go Kajio, Naoki Fujisawa et al. · 2025 · American Heart Journal Plus Cardiology Research and Practice
  47. Using electronic health records to improve cardiovascular-kidney-metabolic health: a protocol for the China Cardiovascular-Kidney-Metabolic Cohort-WeinAn REsearch (CKM-CARE)
    Jingyi Wu, Qianlin Zuo, Weidong Zhang, Jingwei Liu, Shanzhen Fang, Pengfei Li, Luxia Zhang · 2025 · BMJ Open
  48. Therapeutic Considerations in Preventing Chronic Kidney Disease
    Susanne B. Nicholas, Niloofar Nobakht, Radica Z. Alicic · 2025 · Annual Review of Medicine
  49. 2025 Taiwan consensus recommendations for primary care of chronic kidney disease
    Yi‐Chun Tsai, Pei-Yu Wu, Tai‐Shuan Lai, Chih‐Chien Sung, Yi‐Wen Chiu, Shang‐Jyh Hwang, Yung‐Ho Hsu, Mai-Szu Wu, Chung‐Liang Shih · 2025 · Journal of the Formosan Medical Association
  50. Effect of caloric restriction on cardiovascular‐kidney‐metabolic health in young adults: A secondary analysis of the randomised CALERIE trial
    Ryan P. Chang, Brian Lee Claggett, Leanne Maree Redman, Éric Ravussin, Caroline Margaret Apovian, John W. Ostrominski · 2025 · Diabetes Obesity and Metabolism
  51. Changes in the estimated glucose disposal rate and incident cardiovascular disease in patients with cardiovascular–kidney–metabolic syndrome stages 0–3: a prospective cohort study in China
    Jia Liu, Wendong Xu, Yue Zhang, Yuan Jia, Shiru Bai, Lu Er, Rongpin Du · 2025 · BMC Cardiovascular Disorders
  52. Comparison of Risk Stratification Tools for Atherosclerotic Cardiovascular Disease and Cardiovascular–Kidney–Metabolic Syndrome in Primary Care
    Víctor Hugo Vázquez-Martínez, Humberto Martínez-Bautista, Patricia Muñoz‐Villegas, Jesús III Loera Morales, María del Rosario Padilla Salazar · 2025 · Medical Sciences
  53. Developing a Comprehensive Approach for Managing Cardiorenal Metabolic Diseases (CRMD) in Saudi Arabia: Thinking beyond Single Disease—Literature Review and Multidisciplinary Consensus Report
    Abdulrahman Alshaikh, Ali Alshehri, Lamya Mohammed Yahya Alzubaidi, Hussein Elbadawi, Abdulghani Habib Alsaeed, Mohammed S. Almehthel, Raed Aldahash, Fahad Alsabaan, Metib S. Alotaibi, Khalid A Alghamdi et al. · 2025 · Diabetes Therapy
  54. Lean MASH: A High‐Risk Subtype With Significant Cardiometabolic Burden
    Yasser Mahrous Fouad, Alaa Mohamed Mostafa, Ahmed Gomaa, Ziyan Pan, Mohammed Eslam · 2025 · Journal of Gastroenterology and Hepatology
  55. Advancing Cardiorenal Interaction: From Pathophysiological Paradigms to Novel Therapeutic Strategies
    Lei Wei, Peng He, Jingli Gao, Liuyifei Huang, Lijuan Zhao, Ruijing Zhang, Xiaoxuan Ning, Shiren Sun · 2025 · Kidney Diseases
  56. Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies
    Micky Karsten, Sunil V. Badve, Ron T. Gansevoort, Stefan P. Berger, Hiddo J.L. Heerspink, Alferso C Abrahams, Laurent Billot, Rianne H.A.C.M. de Bruin‐Bon, Marielle A. C. J. Gelens, Dean Guinness et al. · 2025 · Clinical Kidney Journal
  57. Integrated TyG index and eGDR measure enhances stroke risk stratification in early cardiovascular-kidney-metabolic syndrome: A prospective national cohort analysis
    Xiaolei Wang, Hongfeng Sun, Taojing Zhang, Hui Zhou · 2025 · Journal of Stroke and Cerebrovascular Diseases
  58. Effect of statin therapy on renal and lipid outcomes in CKM syndrome stage 2: a meta-analysis of randomized controlled trials
    Shuai Lin, Ruxin Liu, Wenrui Huang, L.-Z. Liu, Bing Zhang, Juan Xu, Yanlin Li · 2025 · BMC Nephrology
  59. Remnant cholesterol inflammatory index and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study
    Zhuojing Yang, Li Niu, Yuyan Zhao, Xiaoyi Cao, Lili Wang, Qian Zhao, Jingjing Fan, Juzi Wang · 2025 · Scientific Reports
  60. Serum glycated albumin‐to‐albumin ratio and mortality risk in cardiovascular–kidney–metabolic syndrome: Evidence from NHANES over 15 years
    Zhichao Li, Man Chen · 2025 · Diabetes Obesity and Metabolism
  61. Stage-specific risks of mortality and renal outcomes in cardiovascular-kidney-metabolic syndrome: findings from a nationwide Japanese cohort
    Kenta Fujimoto, Masao Kikuchi, Michikazu Nakai, Tsuneo Konta, Kunitoshi Iseki, Kazuhiko Tsuruya, Kunihiro Yamagata, Ichiei Narita, Toshiki Moriyama, Yugo Shibagaki et al. · 2025 · Clinical and Experimental Nephrology
  62. Prognostic Impact of Cardiovascular‐Kidney‐Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real‐World Multinational Cohort
    Matteo Marchetti, Panagiotis Antiochos, Barbara Pitta Gros, Tamila Abdurashidova, Nisha Soborun, Pierre A Monney, Patrick Yerly, Γεώργιος Τζίμας, Ioannis Skalidis, Péter Vollenweider et al. · 2025 · Journal of the American Heart Association
  63. Prognostic nutritional index predicts staging and mortality in cardiovascular-kidney-metabolic syndrome
    Yiying Liu, Fuyuan Zhang, Ruikang Liu, Jun Li, Cong Chen, Xuanchun Huang, Yulian Yuan, Chao Meng, Xia Xiao, Yonghao Li · 2025 · PLoS ONE
  64. Association of hemoglobin glycation index with the severity and mortality of cardiovascular-kidney-metabolic syndrome: a population-based cohort study
    Leiluo Geng, Xue Diao, Hongjie Yu, Ai-Min Xu · 2025 · Cardiovascular Diabetology – Endocrinology Reports
  65. More than a sidekick: GIP signalling and cardiovascular outcomes
    Berkan Kurt, Florian Kahles · 2025 · European Heart Journal
  66. Gender-related and Age-related Disparities in Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020: An Analysis of the NHANES Survey
    Zhejia Tian, Samira Soltani, Johann K Bauersachs, Kai M. Schmidt-Ott, Anette Melk, Bernhard M.W. Schmidt · 2025 · Kidney Medicine
  67. Inflammation and Oxidative Stress in Cardiovascular-Kidney-Metabolic Syndrome
    Emilia Valasciuc, Evelina Maria Gosav, Daniela Maria Tănase · 2025 · Springer eBooks
  68. Association between cumulative changes of the triglyceride glucose index and incidence of Cardio-cerebral vascular diseases in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study
    Li Hou, Jing Yan Tang, Lei Zhang, Yanhong Li, Yao Niu · 2026 · Journal of Stroke and Cerebrovascular Diseases
  69. The dietary index for gut microbiota and risk of advanced cardio-kidney-metabolic syndrome
    Wei Ji, Qie Zhang, Bing Xin Gao, Yaohui Jiang · 2026 · Clinical and Experimental Medicine
  70. Baseline cardio-kidney-metabolic syndrome, its transition, and frailty: insights from the China Health and Retirement Longitudinal Study (CHARLS)
    Ruixue Duan, Z Y Li, Xuhui Li, Wenxia Ren, Jiaojiao Li, Yajing Bai, Angxian Lü, Yuanyuan Yan, Anqi Zhao, Shiwei Liu · 2026 · European journal of medical research
  71. Circadian disruption is associated with advanced cardio-kidney-metabolic syndrome in overweight and obese adults: evidence from the NHANES database
    Qing Zhang, Tao Ye, Xiao-Lin Zhou, B. Li, Zhen Zhang · 2026 · Nutrition & Metabolism
  72. A Tale of Two Syndromes
    Amir Kazory, Claudio Ronco · 2026 · Kidney360
  73. Therapeutic Advances in Diabetic Kidney Disease: 30 Years of Evidence and the Rise of the “Fantastic Four” in Nephrology
    Faeq Husain‐Syed, Goekhan Yuecel, Clara Daschner, Jan Jochims, Babak Yazdani · 2026 · Cardiorenal Medicine
  74. Effect of Mitochondria‐Derived Methylmalonic Acid on Progress and Mortality Risk in US Adults With Cardiovascular‐Kidney‐Metabolic Syndrome
    Hongyu Liu, Shuang Wu, Bi Huang, Yang Liu, Ziyi Zhong, Manlin Zhao, Yimeng Wang, Tommaso Bucci, Chunyu Liu, Yang Chen et al. · 2026 · Journal of the American Heart Association
  75. Glycaemic Status Modifies the Association Between Cardiometabolic Index and Cardio‐Kidney Outcomes: A Multi‐Cohort Analysis
    Yingyi Xie, Yanjun Song, Shanshan Shi, Guo Yuanlin, Weihua Song, Kefei Dou · 2026 · Diabetes/Metabolism Research and Reviews
  76. Physical Activity and Bidirectional Stage Transitions in Cardiovascular-Kidney-Metabolic Syndrome: A Cohort Study
    Chuan Mou, Xinrui Miao, Zhihua Wang · 2026 · Healthcare
  77. Post-Acute Dyslipidemia and Abnormal Body Mass Index in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative
    Yuqing Lei, Ting Zhou, Bingyu Zhang, D. Zhang, Huilin Tang, Jiajie Chen, Qiong Wu, Lu Li, L. Charles Bailey, Michael John Becich et al. · 2026 · The Journal of Pediatrics
  78. Normalized creatinine-to-cystatin C ratio and cardiovascular disease risk in populations with cardiovascular–kidney–metabolic syndrome stages 0–3: findings from a national and prospective cohort study
    Defei Chen, Yuhui Li, Tailin Ran, Fu Song, Zheng Yang, Weilin Tan, Qiuyi Lu, Lanxin Tang, Lining Yang, Dingqun Bai · 2026 · European journal of medical research
  79. Trends in renal failure-related mortality among adults in the United States: a national cross-sectional analysis (CDC database study 1999–2023)
    Yong Ding, Chang Chen, Bingjie Yang, Kaimo Ding, He Wang · 2026 · BMC Public Health
  80. Association between cardiometabolic index and stage progression in cardiovascular–kidney–metabolic syndrome: insights from a Chinese population-based cohort study
    Si‐qi Lyu, Yang Chen, Yanmin Yang, Juan Wang, Shuang Wu, Li-hui Zheng · 2026 · European journal of medical research
  81. Cardiovascular-kidney-metabolic syndrome: candidate subtypes and genetic risk factors
    Hylke C. Donker, Vartika Bisht, Om Prakash Dwivedi, Stefanie Mueller, Dorien Neijzen, Zhihao Ding, Gerton A. Lunter · 2026 · BMC Medical Genomics
  82. Binational component-wise association between cardiovascular-kidney-metabolic syndrome and life’s essential 8 in South Korea and the US: A nationally representative comparative study
    Yoon Lee, Taelim Choi, Jeongseon Oh, Jaeyu Park, Yesol Yim, Sooji Lee, Hyeseung Lee, André Hajek, Yusheng Li, Jaewon Kim et al. · 2026 · Medicine
  83. The Prevalence of Cardiovascular–Kidney–Metabolic Syndrome: A Review of Published Estimates and New Findings from BRFSS Surveys
    Steven Scott Coughlin, Nikul Parikh, Ashley Oh, Biplab Kumar Datta, Marlo Vernon, Jennifer C. Sullivan · 2026 · Cardiovascular Medicine
  84. Association between sarcopenic obesity and the risk of cardiovascular-kidney-metabolic syndrome progression in Chinese middle-aged and older adults
    Bo Yang, Huanyi Chen, Xiaoqing Xu, Wang Yan · 2026 · Journal of Diabetes & Metabolic Disorders
  85. Ten Hot Topics in Cardiovascular Risk Management for Chronic Kidney Disease
    María Marqués, Alberto Ortíz, Gregorio A. Romero-González, Javier Dı́ez, Rafael Santamaría, Adriana Puente-García, Roberto Alcázar, Patricia de Sequera, José Luis Górriz, Borja Quiroga · 2026 · Cardiorenal Medicine
  86. Intensive Blood Pressure Control and Cardiovascular Outcomes Across Cardiovascular-Kidney-Metabolic Syndrome Stages
    Xiaofan Guo, Shiyu Zhou, Jianjun Mu, Chunxia Zhao, Guozhe Sun, Ying Zhou, Yao Yu, Xiangyu Tan, Yangzhi Yin, Ziyi Xie et al. · 2026 · JAMA Network Open
  87. Association of cardiovascular-kidney-metabolic syndrome stages with MASLD prevalence and liver fibrosis severity: evidence from traditional and machine learning approaches
    Yangyang Zheng, Ting Li, Shiqi Guo, Jinghai Song · 2026 · European journal of medical research
  88. Associations of the triglyceride-glucose index, triglyceride glucose-body mass index, waist-triglyceride index and modified triglyceride-glucose indices with mortality in cardiovascular-kidney-metabolic syndrome stages 0–4: Evidence from NHANES 1999–2020
    Jingya Zhao, Xinning Lu, Hui Wang, Qin Chen, Yigang Wan · 2026 · Journal of Translational Internal Medicine
  89. Modulation of mitochondrial biogenesis by flavonoids via SIRT1 signalling in metabolic syndrome: a systematic review
    Prastuti Sahariah, L. P. Saikia, Albert Bharali, Douglas Sie Nguong Law, Saikat Sen, Partha Pratim Dutta · 2026 · Molecular Biology Reports
  90. Environmental determinants of cardiovascular-kidney-metabolic health: interactive roles of air pollution, heat waves, and green spaces
    Ao Li, Chuangsen Fang, Yanming Li · 2026 · Journal of Global Health
  91. Implications of updated adult hypertension guidelines for the evaluation and management of pediatric patients with high blood pressure
    Carissa Marrie Baker-Smith, Tomáš Seeman · 2026 · Pediatric Nephrology
  92. The association between modified cardiometabolic index and cardiovascular disease risk in adults with early cardiovascular-kidney-metabolic syndrome: a prospective cohort study
    Hongcai Wang, Kaixuan Li, Chang Sheng, Xin Ye, Guoqiang Lin · 2026 · BMC Cardiovascular Disorders
  93. Age-related associations between the CALLY index and advanced cardiovascular-kidney-metabolic (CKM) syndrome: Insights from NHANES population data
    Yi Liu, Yong Li · 2026 · Medicine
  94. Cardiovascular, Kidney, and Metabolic Network Medicine ― Past, Present, and Future Challenges and Directions ―
    Atsushi Tanaka · 2026 · Circulation Journal
  95. Metabolomic biomarkers enhance 10-year mortality risk calibration and clinical utility in older heart failure patients: A UK Biobank study
    Xiaofeng Zeng, Shuli Jia, Wenwu Cheng, Yan Jiang, Jian Xu, Jirong Yue, Li Mo, Chenkai Wu · 2026 · Experimental Gerontology
  96. Triglyceride-glucose index and mortality in critically ill patients with cardiovascular-kidney-metabolic syndrome stage 4
    Xueshi Yin, Shuaixian Han, Zhiming Zheng, Long Tang, Jianping Liu, Yongheng Zhang · 2026 · Cardiovascular Diabetology
  97. Developmental origins and environmental determinants of cardiovascular–kidney–metabolic syndrome: A pediatric precision prevention perspective
    You‐Lin Tain, Chien‐Ning Hsu · 2026 · Biomedical Journal
  98. Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum
    Huannan Wei, Xinyang Long, Mingli Li, Shengzhu Huang, Jianling Li, Zengnan Mo · 2026 · Endocrine
  99. Systemic immune-inflammatory index predicts all-cause and cardiovascular mortality in metabolic syndrome: A prospective cohort study using NHANES data
    Yao Sun, Shuguang Yang, Zengli Xiao, Youzhong An, H. Zhao · 2026 · Clinics
  100. Associations of longitudinal C-reactive protein-triglyceride-glucose and its adiposity-related derivatives with frailty onset and progression in cardiovascular-kidney-metabolic syndrome stages 0–3: a national prospective cohort study
    Fengqin Li, Yue Wu, Yanzhe Wang, Jialing Wang, Jialing Wang, Xinyue Chen, Tong Wu, Xiaoxia Wang · 2026 · Archives of Gerontology and Geriatrics